National Health Cost & Accountability Act of 2025 (NHCAA)

 National Health Cost & Accountability Act of 2025 (NHCAA)

Umbrella healthcare reform bill built from prior enacted-draft texts and standards; structured in HOLC style for congressional submission.


Plain‑English Summary (Checkmarks)

  • It’s a price‑gouging crisis, not a care crisis. Caps prices to OECD‑benchmarks and outlaws junk “facility fees.”
  • Essential medicines become affordable by design. Insulin and life‑saving drugs get strict price controls, transparency, and nonprofit manufacturing backstops.
  • Real transparency with teeth. Mandatory up‑front pricing for hospitals, clinics, labs, imaging; daily fines for non‑compliance.
  • Youth protection. Restricts high‑caffeine marketing/sales to minors; bans caffeinated drinks in K–12.
  • Workplace health is healthcare. OSHA‑aligned indoor‑air, chemical, and ergonomic standards tied to payer participation.
  • Pets are family. National pet healthcare framework (subsidies + pricing standards) to end euthanasia by cost.
  • Nonprofit-first model. Incentivizes hospital nonprofit conversion and ties executive compensation to median staff pay.

Table of Contents

  • Title I — Findings; Purpose; Definitions
  • Title II — National Price Standards & Anti‑Gouging
  • Title III — Hospital & Insurer Transparency
  • Title IV — Essential Medicines & Insulin Affordability
  • Title V — Youth Health & Caffeine Controls
  • Title VI — Workplace Health Standards (Healthcare Linkage)
  • Title VII — Veterinary & Public Health Integration
  • Title VIII — Oversight, Enforcement, and Penalties
  • Title IX — Funding; Implementation; Reports
  • Title X — General Provisions (Severability; Effective Date)

Title I — Findings; Purpose; Definitions

Sec. 101. Findings

  1. The United States pays the highest healthcare prices among peer nations, absent effective national price regulation.
  2. Price opacity and market consolidation permit extraction of economic rents, not correlated with outcomes.
  3. Essential medicines (including insulin) and emergency therapeutics must be accessible at predictable, regulated prices.
  4. Youth exposure to high‑caffeine beverages correlates with adverse physical and mental outcomes; schools require protective standards.
  5. Workplace health (air quality, chemical exposure, ergonomics) directly drives morbidity and payer costs; federal standards must be harmonized and enforced.
  6. Companion‑animal healthcare costs create household distress and public‑health externalities; basic veterinary access is in the national interest.

Sec. 102. Purpose

To treat healthcare as a regulated public utility with (1) national price standards, (2) universal transparency, (3) essential‑medicine affordability, (4) youth protections, (5) integrated workplace‑health enforcement, and (6) companion‑animal care access.

Sec. 103. Definitions

Key terms shall include: "essential medicine," "benchmark price," "facility fee," "payer," "provider," "youth/high‑caffeine beverage," "covered veterinary service," and others as defined by the Secretary in rulemaking.


Title II — National Price Standards & Anti‑Gouging

Sec. 201. Benchmark Price Caps

(a) The Secretary shall set national benchmark prices for ER visits, imaging, labs, inpatient DRGs, and common outpatient procedures at ≤150% of OECD median for equivalent services.
(b) Annual adjustments follow CPI‑U or 2%, whichever is lower, unless evidence shows a quality‑of‑care compromise.

Sec. 202. Facility Fee Reform

(a) Prohibits non‑hospital outpatient "facility fees" unless clinically required and pre‑disclosed; violations result in per‑claim civil penalties.

Sec. 203. Anti‑Consolidation & Ownership Conflicts

(a) Bars common ownership/control between hospitals, insurers, and PBMs beyond de‑minimis thresholds; requires divestiture plans.


Title III — Hospital & Insurer Transparency

Sec. 301. Real‑Time Price Disclosure

(a) Providers must publish consumer‑facing prices (bundled and itemized) for all shoppable services.
(b) Non‑compliance: daily fines scaled by system revenue; repeat violations trigger Medicare/Medicaid participation holds.

Sec. 302. Advance Cost Estimates

(a) Mandates written good‑faith estimates before non‑emergent care; bans surprise billing across all provider types.


Title IV — Essential Medicines & Insulin Affordability

Sec. 401. Insulin Affordability & Access

(a) Insulin subject to national ceiling price; mandatory coverage at $0 copay for chronic users; distribution safeguards for purity and authenticity.
(b) Corporate transparency on cost of goods (COGS), R&D tax credits, and transfer pricing; penalties for misreporting.

Sec. 402. Essential Medicines Program

(a) Establishes a federal nonprofit generics manufacturer to supply designated essential medicines during price spikes or shortages.
(b) Caps annual list‑price increases at CPI‑U (or 2%).

Sec. 403. Corporate Incentives & Oversight

(a) Temporary tax credits for voluntary price reductions meeting federal targets; clawbacks for non‑compliance.
(b) Annual public reporting; independent audit authority.


Title V — Youth Health & Caffeine Controls

Sec. 501. Labeling & Marketing Restrictions

(a) Prominent caffeine warnings; bans targeted marketing of high‑caffeine beverages to individuals under 16.

Sec. 502. Age‑Restricted Sales & School Protections

(a) Prohibits sale of high‑caffeine beverages to persons under 16.
(b) Bans caffeinated beverages in K–12 campuses, with enforcement by state education agencies.


Title VI — Workplace Health Standards (Healthcare Linkage)

Sec. 601. OSHA‑Linked Health Compliance

(a) Aligns payer participation with demonstrable compliance on indoor air quality (IAQ), chemical exposure controls (e.g., fume hoods), and ergonomics.
(b) Requires annual IAQ testing and HVAC maintenance; establishes whistleblower safe‑harbors; ties repeated violations to federal contracting eligibility.


Title VII — Veterinary & Public Health Integration

Sec. 701. Federal Veterinary Care Subsidy Program (FVCS)

(a) Sliding‑scale subsidies up to 80% for eligible households (≤300% FPL) covering routine, emergency, diagnostics, meds.

Sec. 702. Federal Pet Health Insurance Program (FPHIP)

(a) Affordable national plans with chronic‑care coverage and minimized cost‑sharing for low‑income households.

Sec. 703. Veterinary Pricing Standards & Transparency

(a) Standardized pricing schedules for common procedures; mandatory up‑front quotes.

Sec. 704. Vector‑Borne Disease Control & Research

(a) Authorizes R&D on sustainable vector control (including targeted irradiation and immunity‑based approaches) with environmental safeguards.


Title VIII — Oversight, Enforcement, and Penalties

Sec. 801. Independent Health Pricing Commission

(a) Sets/updates benchmarks; investigates gouging; recommends civil/criminal referrals.

Sec. 802. Data, Audits, and Whistleblowers

(a) Robust data‑submission authority; audit rights; anti‑retaliation protections with statutory damages.

Sec. 803. Penalties

(a) Scaled civil penalties for price and transparency violations; treble damages for willful fraud; exclusion authority for repeat offenders.


Title IX — Funding; Implementation; Reports

Sec. 901. Appropriations

(a) Such sums as necessary; CBO‑scorable offsets via waste‑reduction and anti‑gouging recoveries.

Sec. 902. Implementation Timeline

(a) 12 months for rulemaking; staged go‑live for Titles II–VII.

Sec. 903. Reports to Congress

(a) Annual public reports on price trends, access, outcomes, and enforcement actions.


Title X — General Provisions

Sec. 1001. Severability

If any provision is held invalid, the remainder remains in effect.

Sec. 1002. Effective Date

This Act takes effect 90 days after enactment unless otherwise specified.


Notes for Drafting Team (Internal)

  • Conform terminology and numbering to House Office of Legislative Counsel (HOLC) style.
  • Attach regulatory cross‑walks to existing CFR titles (OSHA, HHS/CMS, FDA) in the drafting memo.
  • Prepare one‑page Hill summary, press sheet, and citizen explainer.
  • Build annexes: (A) OECD price tables; (B) Essential‑medicine list; (C) IAQ/chemical standards; (D) Youth caffeine evidence brief; (E) Veterinary pricing model.

 

Comments

Popular posts from this blog

Why a $2 Million AI Prize Won’t Fix U.S. Healthcare PArt 2

Why a $2 Million AI Prize Won’t Fix U.S. Healthcare part 1

Unhealthy Eating for Teenagers: A Reality-Based Public Health Curriculum